Divi's Laboratories Limited (DIVISLAB) — Board Meeting | 6 August 2025(2 announcements)
Divi's Laboratories Limited board amended its Policy on Determination of Materiality Disclosure of Events or Information on August 6, 2025. The amendment updated designated officials responsible for determining materiality and disclosing material events to stock exchanges. Key contacts include Managing Director Dr. Murali K. Divi, CEO Dr. Kiran S. Divi, and CFO Venkatesa Perumallu Pasumarthy, with disclosure authority assigned to the CFO and Company Secretary.
Divi's Laboratories reported Q1 FY2025-26 consolidated total income of ₹2,529 crores versus ₹2,197 crores YoY (15% growth), with profit before tax of ₹733 crores versus ₹604 crores YoY. Consolidated net profit reached ₹545 crores compared to ₹430 crores in the prior-year quarter. Forex gains contributed ₹39 crores versus a ₹1 crore loss previously. On standalone basis, total income was ₹2,476 crores and PAT was ₹557 crores.
About Divi's Laboratories Limited (DIVISLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when DIVISLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track DIVISLAB — Free💡 Ask AI about this filing
📊 More DIVISLAB filings
- 🟡 Board Meeting — 10 August 2026 Divi's Laboratories held its 36th AGM on August 10, 2026, via video conferencing, where shareholders...
- 🔴 Financial Results — 6 August 2026 Divi's Laboratories reported consolidated revenue of ₹3,144 crores and profit after tax of ₹902 cror...
- Announcement — 1 August 2026 Divi's Laboratories announced its August 1, 2026 board meeting outcomes, approving unaudited standal...
- 🟡 Board Meeting — 1 August 2026 Divi's Laboratories reported unaudited standalone financial results for Q1 FY2026 ending June 30, 20...
- Announcement — 1 August 2026 Divi's Laboratories announced that the audio recording of its Q1 FY27 earnings conference call held ...
🔥 Also filed on 6 August 2025
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DIVISLAB files new disclosures
Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DIVISLAB — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research